The enhancement of retention performance induced by picrotoxin in mice may be mediated through a release of endogenous vasopressin

Behavioural Pharmacology

Volumn 7, Issue 3, 1996, Pages 254-260

  Boccia, M M ^a   Kopf, S R ^a   Baratti, C M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

GABA; GABA(A) antagonists; Inhibitory avoidance; Mouse; Picrotoxin; Retention performance; Vasopressin; Vasopressin receptor antagonists

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; PICROTOXIN; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN [1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE) 8 DEXTRO ARGININE];

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG MECHANISM; ELECTRIC SHOCK; MALE; MEMORY; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; VASOPRESSIN RELEASE;

EID: 0029902639     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199605000-00006     Document Type: Article

References (55)

1. Baratti CM, Faiman CP and de Erausquin GA (1989) Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist. Behavioral and Neural Biology, 51, 424-435.
2. Bovet D, McGaugh JL and Oliverio A (1966) Effects of post-trial administration of drugs on avoidance learning in mice. Life Science, 5, 1309-1315.
3. Breen RA and McGaugh JL (1961) Facilitation of maze learning with post-trial injections of picrotoxin. Journal of Comparative Physiology and Psychology, 54, 498-501.
4. Brioni JD (1993) Role of GABA during multiple consolidation of memory. Drug Development Research, 28, 3-27.
5. Brioni JD and McGaugh (1988) Post-training administration of GABAergic antagonists enhances retention of aversively motivated tasks. Psychopharmacology, 96, 505-510.
6. Castellano C and McGaugh (1989) Retention enhancement with post-training picrotoxin: lack of state-dependency. Behavioral and Neural Biology, 51, 165-170.
7. Castellano C and Pavone F (1988) Effects of ethanol on passive avoidance in the mouse: involvement of GABAergic mechanisms. Pharmacology Biochemistry and Behavior, 29, 321-324.
8. Curtis DR, Duggan AW, Felix D and Johnson GAR (1970) GABA, bicuculline and central inhibiton. Nature, 226, 1222-1224.
9. De Wied D, Gaffori O, van Ree JM and de Jong W (1984a) Central target for the behavioral effects of vasopressin neuropeptides. Nature, 308, 276-278.
10. De Wied D, Gaffori O, van Ree JM and de Jong W (1984b) Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmacology Biochemistry and Behavior, 21, 393-400.
11. De Wied D, Diamant M and Fodor M (1993) Central nervous system effects of the neurohypophyseal hormones and related peptides. Frontiers in Neuroendocrinology, 14, 251-302.
12. Dunn FL, Brennan TJ, Nelson AE and Robertson GL (1973) The role of blood osmolality and volume in regulating vasopressin secretion in the rat. Journal of Clinical Investigation, 52, 3212-3219.
13. Ettenberg A (1984) Intracerebroventricular application of a vasopressin antagonist prevents both the "memory" and "aversive" actions of vasopressin. Behavioural Brain Research, 14, 201-211.
14. Faiman CP, de Erausquin GA and Baratti CM (1991) The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms. Behavioral and Neural Biology, 56, 183-199.
15. Garg M (1970) Combined effect of drug and drive on the consolidation processes. Psychopharmacologia, 18, 172-179.
16. Garg M and Holland HC (1968) Consolidation and maze learning: the effects of post-trial injections of a stimulant drug (picrotoxin). Psychopharmacologia, 12, 96-103.
17. Gold PE (1986) The use of avoidance training in studies of modulation of memory storage. Behavioral and Neural Biology, 48, 87-98.
18. Gold PE (1992) Modulation of memory processing: enhancement of memory in rodents and humans. In: Neuropsychology of Memory (Eds LR Squire and N Butters), pp. 402-414. Guilford Press, New York.
19. Gold PE and Van Buskirk RB (1976) Enhancement and impairment of memory processes with post-trial injections of adrenocorticotrophic hormone. Behavioral Biology, 16, 387-400.
20. Gold PE and Van Buskirk RB (1978) Post-training brain norepinephrine concentration: correlation with retention performance of avoidance training and with peripheral epinephrine modulation of memory processing. Behavioral Biology, 23, 509-520.
21. Grecksch G and Matthies H (1981) Differential effects of intrahippocampal or systemically applied picrotoxin on memory consolidation in rats. Pharmacology Biochemistry and Behavior, 14, 613-616.
22. Hedge GA and Huffman LJ (1987) Vasopressin and endocrine function. In: Vasopressin Principles and Properties (Eds DM Gash and GJ Boer), pp. 435-475. Plenum Press, New York.
23. Izquierdo I (1994) Pharmacological evidence for a role of longterm potentiation in memory. FASEB Journal, 8, 1139-1145.
24. Izquierdo I and Diaz RD (1984) Involvement of α-adrenergic receptors in the amnestic and antiamnestic actions of ACTH, β-endorphin and epinephrine. Psychoneuroendocrinology, 9, 77-81.
25. Izquierdo I and Diaz RD (1985) Influence on memory of post-training or pre-test injections of ACTH, vasopressin, epinephrine, and β-endorphin and their interactions with naloxone. Psychoneuroendocrinology, 10, 165-172.
26. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M and Sawyer WH (1986) Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Molecular Pharmacology, 30, 171-177.
27. Johnston GAR (1986) Multiplicity of GABA receptor. In: Benzodiazepine GABA Receptors and Chloride Channels: Structural and Functional Properties (Eds R Olsen and JC Venter), pp. 57-71. Alan R Liss, New York.
28. Koob GF, Lebrun C, Martinez JL, Dantzer R, Le Moal M and Bloom FE (1985). Arginine vasopressin, stress and memory. In: Vasopressin (Ed R Schrier), pp. 195-201. Raven Press, New York.
29. Koob GF, Lebrun C, Bluthe RM, Dantzer R and Le Moal M (1989) Role of neuropeptides in learning performance: focus on vasopressin. Brain Research, 23, 359-364.
30. Kopf SR and Baratti CM (1994) Memory-improving actions of glucose: involvement of central cholinergic muscarinic mechanisms. Behavioral and Neural Biology, 62, 237-243.
31. Kopf SR and Baratti CM (1995a) The impairment of retention induced by insulin in mice may be mediated by a reduction in central cholinergic activity. Neurobiology of Learning and Memory, 63, 220-228.
32. Kopf SR and Baratti CM (1995b) Memory modulation by post-training glucose or insulin remains evident at long retention intervals. Neurobiology of Learning and Memory (in press).
33. Kopf SR, Opezzo JW and Baratti CM (1993) Glucose enhancement of memory is not state-dependent. Behavioral and Neural Biology, 60, 192-195.
34. Kovàcs GL and De Wied D (1994) Peptidergic modulation of learning and memory processes. Phamacological Reviews, 46, 269-291.
35. Kruszynski M, Lammek B, Manning M, Seto J, Haldar J and Sawyer WH (1980) (1-(β-mercapto-β,β-cyclopentamethylene-propionic acid), 2-(o-methyl) tyrosine) arginine vasopressin and (1-β-mercapto-β,β-cyclopentamethylenepropionic acid) arginine vasopressin, two highly potent antagonists of vasopresser response to arginine vasopressin. Journal of Medicinal Chemistry, 23, 364-368.
36. Lebrun C, Le Moal M, Koob GF and Bloom FE (1985) Vasopressin pressor antagonist injected centrally reverses peripheral behavioral effect of vasopressin but only at doses that reverse increases in blood pressure. Regulatory Peptides, 11, 173-181.
37. Le Moal M, Koob GF, Koda LY, Bloom FE, Manning M, Sawyer WH and Rivier J (1981) Vasopressor receptor antagonist prevents behavioral effects of vasopressin. Nature, 291, 491-493.
38. Manning M and Sawyer WH (1993) Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. Journal of Receptor Research, 13, 195-214.
39. McGaugh JL (1966) Time-dependent processes in memory storage. Science, 153, 1351-1358.
40. McGaugh JL (1989) Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annual Review of Neuroscience, 12, 255-287.
41. Nabeshima T, Noda Y and Kameyama T (1988) GABAergic modulation of memory with regard to passive avoidance and conditioned suppression tasks in mice. Psychopharmacology, 94, 69-73.
42. A receptors. FASEB Journal, 4, 1469-1480.
43. Olsen RW, Ticku MK and Miller T (1978). Dihydropicrotoxin binding to crayfish muscle sites probably related to γ-amino-butyric acid receptor-ionophores. Molecular Pharmacology, 14, 381-390.
44. Palacios JM, Wamsley JK and Kuhar MJ (1981) High affinity GABA receptors: autoradiographic localization. Brain Research, 222, 285-307.
45. Petersen EN and Jensen LH (1984) Proconflict effects of benzodiazepine receptor inverse agonists and other inhibitors of GABA function. European Journal of Pharmacology, 103, 91-97.
46. Pong SF and Graham LT (1972) N-methyl bicuculline, a convulsant more potent than bicuculline. Brain Research, 42, 486-490.
47. Rodriguez R, Demotes-Mainard J, Chaveau J, Poulain D and Vincent JP (1983) Vasopressin release in response to systemic stimuli. Society for Neuroscience Abstracts, 9, 445.
48. Sahgal A (1984) A critique of the vasopressin memory hypothesis. Psychopharmacology, 83, 215-288.
49. Sahgal A and Wright C (1984) Choice as opposed to latency, measured in avoidance, suggest that vasopressin and oxytocin do not affect memory in rats. Neuroscience, 48, 299-304.
50. Siegel S (1956) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.
51. Sladek CD and Armstrong WE (1987a) γ-Aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants. Endocrinology, 120, 1576-1580.
52. Sladek CD and Armstrong WE (1987b) Effect of neurotransmitters and neuropeptides on vasopressin release. In: Vasopressin Principles and Properties (Eds DM Gash and GJ Boer), pp. 275-333. Plenum Press, New York.
53. Soubrie P, Thiebot M and Simon P (1979) Enhanced suppressive effects of aversive events induced in rats by picrotoxin: possibility of a GABA control on behavioral inhibition. Pharmacology Biochemistry and Behavior, 10, 463-469.
54. Yamanaka K, Yamada S, Okada T and Hayashih (1983). Effect of picrotoxin on adrenal catecholamine secretion. Japanese Journal of Pharmacology, 33, 1049-1055.
55. Yonkov DI and Georgiev (1985) Memory effects of GABAergic antagonists in rats trained with two-way active avoidance tasks. Acta Phvsiologica et Pharmacologie a Bulgarica, 11, 44-49.